149 related articles for article (PubMed ID: 26211476)
1. Recombinant disintegrin domain of human ADAM9 inhibits migration and invasion of DU145 prostate tumor cells.
Martin AC; Cardoso AC; Selistre-de-Araujo HS; Cominetti MR
Cell Adh Migr; 2015; 9(4):293-9. PubMed ID: 26211476
[TBL] [Abstract][Full Text] [Related]
2. ADAM9 silencing inhibits breast tumor cell invasion in vitro.
Micocci KC; Martin AC; Montenegro Cde F; Durante AC; Pouliot N; Cominetti MR; Selistre-de-Araujo HS
Biochimie; 2013 Jul; 95(7):1371-8. PubMed ID: 23499592
[TBL] [Abstract][Full Text] [Related]
3. The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.
Zigrino P; Nischt R; Mauch C
J Biol Chem; 2011 Feb; 286(8):6801-7. PubMed ID: 21135106
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.
Cominetti MR; Martin AC; Ribeiro JU; Djaafri I; Fauvel-Lafève F; Crépin M; Selistre-de-Araujo HS
Biochimie; 2009 Aug; 91(8):1045-52. PubMed ID: 19505527
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
Chang L; Gong F; Cui Y
Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
[TBL] [Abstract][Full Text] [Related]
8. The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression.
Kim JM; Jeung HC; Rha SY; Yu EJ; Kim TS; Shin YK; Zhang X; Park KH; Park SW; Chung HC; Powis G
Mol Cancer Ther; 2014 Dec; 13(12):3074-85. PubMed ID: 25344581
[TBL] [Abstract][Full Text] [Related]
9. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.
Mahimkar RM; Visaya O; Pollock AS; Lovett DH
Biochem J; 2005 Jan; 385(Pt 2):461-8. PubMed ID: 15361064
[TBL] [Abstract][Full Text] [Related]
10. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.
Mazzocca A; Coppari R; De Franco R; Cho JY; Libermann TA; Pinzani M; Toker A
Cancer Res; 2005 Jun; 65(11):4728-38. PubMed ID: 15930291
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
[TBL] [Abstract][Full Text] [Related]
12. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
[TBL] [Abstract][Full Text] [Related]
14. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
Zolkiewska A
Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632
[TBL] [Abstract][Full Text] [Related]
15. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.
Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW
Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
18. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
19. The pleiotropic roles of ADAM9 in the biology of solid tumors.
Oria VO; Lopatta P; Schilling O
Cell Mol Life Sci; 2018 Jul; 75(13):2291-2301. PubMed ID: 29550974
[TBL] [Abstract][Full Text] [Related]
20. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
